News

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...
Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and ...
Comedians have long used jokes to raise awareness of serious problems, and many are now turning the gaze to climate change.
Health and Human Services Secretary Robert F. Kennedy Jr. this week made his strongest endorsement yet of the measles vaccine amid an ongoing outbreak that has killed three and infected more than ...
PNEUMOVAX 23 contains a mixture of inactive parts from 23 of the most common types of pneumococcal bacteria. PNEUMOVAX 23 is a vaccine given to help prevent infections caused by certain types of ...
Did you know there are more than 20 life-threatening diseases that can be prevented with vaccines? Here are a few more interesting facts on the subject. Yes, it has a funny name, but whooping ...
Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic ...
Adults 19 and older with sickle cell disease who have not received a pneumococcal conjugate vaccine (PCV) should receive a single dose of either Vaxneuvance (PCV15), Prevnar 20 (PCV20), or Capvaxive ...